Skip to content
Catalyst briefs

What to know before each readout

One page per upcoming Phase 3 readout at a listed company. Facts first, each with its source. Rebuilt every night.

DaysTickerTrialRegistry dateFactsAnalyst desk
12VNDATradipitant1 Dec 202617yes
26AXSMENGAGEDec 202619yes
26MDWDVALUEDec 202613yes
26KRYSIOLITEDec 202616yes
26PRAXEMERALDDec 202620yes
26UTHRRalinepagDec 202615yes
26MANEVDPHL01Dec 202615yes
26VIRTobevibartDec 202616yes
26EXELSTELLAR-30415 Dec 202618yes
26IONSDonidalorsenDec 202619yes
26DMACReMEDy2Dec 202616yes
26KPTIQSelinexor (combination therapy)Dec 202618yes

How this page is made: the facts come straight from the trial registry, SEC filings and FDA records, each with its link. AI analysts may only restate those facts, and any sentence with a number that is not in a cited fact is removed before publishing. How our models work. Dates are company-reported estimates. Information only, not investment or medical advice.